相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sugammadex in end-stage renal disease: too early for a free-pass
Rohan Magoon et al.
CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2021)
In reply: Sugammadex in end-stage renal disease: too early for a free-pass
J. Ross Renew et al.
CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2021)
Nephroprotective Efficacy of Sugammadex in Ischemia-Reperfusion Injury: An Experimental Study in a Rat Model
Mehmet Tercan et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2021)
Short-term safety and effectiveness of sugammadex for surgical patients with end-stage renal disease: a two-centre retrospective study
D. R. Adams et al.
ANAESTHESIA (2020)
Sugammadex use in patients with end-stage renal disease: a historical cohort study
Stephania Paredes et al.
CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2020)
Efficacy and safety of sugammadex in patients undergoing renal transplantation
Yasumasa Ono et al.
JA CLINICAL REPORTS (2018)
Pharmacokinetics of sugammadex in subjects with moderate and severe renal impairment
K. Chris Min et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2017)
The use of rocuronium and sugammadex in paediatric renal transplantation Two case reports
Ricardo Vieira Carlos et al.
EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Rocuronium-sugammadex use for electroconvulsive therapy in a hemodialysis patient: a case report
Shigeaki Kurita et al.
JA CLINICAL REPORTS (2016)
Efficacy, safety and pharmacokinetics of sugammadex 4 mg kg-1 for reversal of deep neuromuscular blockade in patients with severe renal impairment
I. F. Panhuizen et al.
BRITISH JOURNAL OF ANAESTHESIA (2015)
Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end-stage renal disease A comparative prospective clinical trial
Camila M. de Souza et al.
EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2015)
Prolonged recovery time from muscle relaxation due to rocuronium in patients with severe chronic renal disease using sugammadex
A. Maeyama et al.
EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2014)
Dialysability of sugammadex and its complex with rocuronium in intensive care patients with severe renal impairment
G. Cammu et al.
BRITISH JOURNAL OF ANAESTHESIA (2012)
Sugammadex is cleared rapidly and primarily unchanged via renal excretion
Pierre Peeters et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2011)
Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study
L. M. Staals et al.
BRITISH JOURNAL OF ANAESTHESIA (2010)
Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function
L. M. Staals et al.
BRITISH JOURNAL OF ANAESTHESIA (2008)
Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study - Efficacy, safety, and pharmacokinetics
Harald J. Sparr et al.
ANESTHESIOLOGY (2007)
Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex - A dose-finding and safety study
IF Sorgenfrei et al.
ANESTHESIOLOGY (2006)
Reversal of neuromuscular blockade and simultaneous increase in plasma rocuronium concentration after the intravenous infusion of the novel reversal agent Org 25969
O Epemolu et al.
ANESTHESIOLOGY (2003)
分享论文
